학술논문

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
Document Type
Article
Source
In: AIDS. (AIDS, 1 July 2023, 37(8):1227-1237)
Subject
Language
English
ISSN
14735571
02699370